TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive Clearinghouse Delves Into Carcinogenesis Issues – Test Validity, Interpretation, In Vitro Methods August 12, 1977